Peptide research,
without the fog.
Source-labeled research summaries, protocol context, COA education, and documentation-first industry analysis.
Start with the question you have.
The Index is organized around research context, study reporting, documentation, and market accountability.
Research Overviews
Mechanisms, study designs, and literature context.
Benefits & Uses
What published sources actually discuss.
Reported Protocols
Study details reported by cited sources—not instructions.
COA & Documentation
Identity, purity, batches, and analytical records.
Industry Red Flags
Claims, gaps, and warning signs worth checking.
Research Checklists
Practical documentation-first review tools.
Latest articles
Tesamorelin Randomized Trials: Arms, Controls, and Reported Protocol Details
A study-by-study summary of randomized Tesamorelin trial arms, controls, and protocol details reported by cited sources.
Tesamorelin and IGF-1: What Clinical Studies Reported
A source-labeled review of IGF-1 measurements, timing, trial context, and limitations in Tesamorelin research.
Tesamorelin and Liver-Fat Research: Trial Designs and Reported Findings
A literature-context review of hepatic-fat measurements and trial designs reported in Tesamorelin research.
Tesamorelin and Visceral Adipose Tissue: What Clinical Trials Measured
A source-labeled review of visceral-adipose-tissue endpoints, imaging methods, timepoints, and study designs used in Tesamorelin trials.
GHK-Cu Evidence Map: Human, Animal, and Cell Research Compared
A structured evidence map separating human, animal, and cell findings so different levels of GHK-Cu evidence are not conflated.
GHK Plasma Levels and Age-Related Research
A source-labeled review of reported GHK levels in human biological samples, age-related observations, and evidence limitations.
A claim is not documentation.
Peptide Bio Index separates what sources report from what marketing implies. Missing details stay missing. Weak evidence stays labeled.
Read our methodology →